561 related articles for article (PubMed ID: 34712025)
1. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases.
Sharma SP; Suk KT; Kim DJ
World J Gastroenterol; 2021 Oct; 27(37):6161-6179. PubMed ID: 34712025
[TBL] [Abstract][Full Text] [Related]
2. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.
Park JW; Kim SE; Lee NY; Kim JH; Jung JH; Jang MK; Park SH; Lee MS; Kim DJ; Kim HS; Suk KT
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008852
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota and Complications of Liver Disease.
Acharya C; Bajaj JS
Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
[TBL] [Abstract][Full Text] [Related]
4. Impacts of gut microbiota alteration on age-related chronic liver diseases.
Adhikary S; Esmeeta A; Dey A; Banerjee A; Saha B; Gopan P; Duttaroy AK; Pathak S
Dig Liver Dis; 2024 Jan; 56(1):112-122. PubMed ID: 37407321
[TBL] [Abstract][Full Text] [Related]
5. Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future.
Lang S; Schnabl B
Cell Host Microbe; 2020 Aug; 28(2):233-244. PubMed ID: 32791115
[TBL] [Abstract][Full Text] [Related]
6. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
7. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and non-alcoholic fatty liver disease.
Abenavoli L; Procopio AC; Scarpellini E; Polimeni N; Aquila I; Larussa T; Boccuto L; Luzza F
Minerva Gastroenterol (Torino); 2021 Dec; 67(4):339-347. PubMed ID: 33871224
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease.
Yang YJ; Ni YH
J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S55-S61. PubMed ID: 30509561
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
Boursier J; Diehl AM
Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268
[TBL] [Abstract][Full Text] [Related]
11. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.
Jennison E; Byrne CD
Clin Mol Hepatol; 2021 Jan; 27(1):22-43. PubMed ID: 33291863
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome and non-alcoholic fatty liver disease.
Purohit A; Alam MJ; Kandiyal B; Shalimar ; Das B; Banerjee SK
Prog Mol Biol Transl Sci; 2022; 191(1):187-206. PubMed ID: 36270678
[TBL] [Abstract][Full Text] [Related]
13. Alcohol, liver disease and the gut microbiota.
Bajaj JS
Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota mediated molecular events and therapy in liver diseases.
Qi X; Yang M; Stenberg J; Dey R; Fogwe L; Alam MS; Kimchi ET; Staveley-O'Carroll KF; Li G
World J Gastroenterol; 2020 Dec; 26(48):7603-7618. PubMed ID: 33505139
[TBL] [Abstract][Full Text] [Related]
15. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
Leclercq S; de Timary P; Stärkel P
Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome and nonalcoholic fatty liver disease.
Wu MY; Fan JG
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):444-451. PubMed ID: 37308360
[TBL] [Abstract][Full Text] [Related]
17. Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms.
Bakhshimoghaddam F; Alizadeh M
Clin Nutr ESPEN; 2021 Aug; 44():61-68. PubMed ID: 34330514
[TBL] [Abstract][Full Text] [Related]
18. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
Rajani C; Jia W
Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
20. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function.
Sharpton SR; Ajmera V; Loomba R
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):296-306. PubMed ID: 30196156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
